No products in the cart.
ANAFRONIL 25 MG 30 TAB
45.00 EGP
In stock
| * Therapeutic indications: | ||
| # Treatment of depressive states of varying aetiology and symptomatology, e.g. | ||
| – endogenous, reactive, neurotic, organic, masked, and involutional forms of depression, | ||
| – depression associated with schizophrenia and personality disorders, | ||
| – depressive syndromes due to presenility or senility, to chronic painful conditions, and | ||
| & chronic somatic diseases. | ||
| – depressive mood disorders of a reactive, neurotic, or psychopathic nature. | ||
| # Obsessive-compulsive syndromes. | ||
| # Phobias and panic attacks. | ||
| # Cataplexy accompanying narcolepsy. | ||
| # Chronic painful conditions. | ||
| # Nocturnal enuresis (only in patients over the age of 5 and if organic causes have been excluded). | ||
| * Posology and method of administration: | ||
| – The dosage and method of administration should be adapted to the individual patient’s condition. | ||
| & The aim is to achieve an optimum effect while keeping the doses as low as possible and increasing them | ||
| & cautiously, particularly in elderly patients or adolescents, who generally show a stronger response to | ||
| & Anafronil than patients of intermediate age groups. | ||
| – Depression, obsessive-compulsive syndromes, and phobias: Start treatment with 1 coated tablet of 25 mg | ||
| & 2-3 times daily or 1 sustained-release tablet of 75 mg once daily (preferably in the evening). Raise the daily | ||
| & dosage stepwise, e.g. 25 mg every few days, (depending on how the medication is tolerated) to 4-6 tablets | ||
| & of 25 mg or 2 sustained-release tablets of 75 mg during the first week of treatment. In severe cases this dosage | ||
| & can be increased up to a maximum of 250 mg daily. Once there is a distinct improvement, adjust the daily dosage | ||
| & to a maintenance level of about 2-4 coated tablets of 25 mg or 1 modified-release tablet of 75 mg. | ||
| – Panic attacks, agoraphobia: Start with 1 tablet of 10 mg daily, possibly in combination with a benzodiazepine. | ||
| & Depending on how the medication, while gradually withdrawing the benzodiazepine. The daily dosage required | ||
| & varies greatly from patient to patient and lies between 25 and 100 mg. If necessary it can be increased to 150mg. | ||
| & It is advisable for treatment not to be dicontinued for at least 6 months and for the maintenance dose to be | ||
| & reduced slowly during this time. | ||
| – Cataplexy accompanying narcolepsy: Daily dose of 25-75 mg. | ||
| – Chronic painful conditions: The dosage must be individualised (10-150 mg daily), while taking account of | ||
| & concomitant analgesic medication (and of the possibility of reducing use of analgesics). | ||
| – Elderly patients: Start treatment with 1 tablet of 10 mg daily. Gradually raise the dosage to an optimum level of | ||
| & 30-50 mg daily, which should be reached after about 10 days and then maintained until the end of treatment. | ||
– Nocturnal enuresis: Initial
Q & AThere are no questions yet
Ask a question Your question will be answered by a store representative or other customers. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you for the question! Your question has been received and will be answered soon. Please do not submit the same question again. Error 
An error occurred when saving your question. Please report it to the website administrator. Additional information: Add an answer This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you for the answer! Your answer has been received and will be published soon. Please do not submit the same answer again. Error
An error occurred when saving your answer. Please report it to the website administrator. Additional information: Related products
أدوية مضادة للاكتئاب
85.75 EGP
أدوية مضادة للاكتئاب
89.00 EGP
أدوية مضادة للاكتئاب
84.00 EGP
أدوية مضادة للاكتئاب
59.00 EGP
|